Mycetoma Clinically Masquerading as Squamous Cell Carcinoma
February 2009
Case Report and Literature Review Read the rest of this article »
Posted in 02-2009 (February 2009), Case Report, General, Literature Review, Mycetoma | No Comments »
Treatment of Scalp and Facial Seborrheic Dermatitis with Desonide Hydrogel 0.05%
February 2009
Leon H. Kircik, MD
DermResearch PLLC, Louisville, Kentucky; Indiana University, School of Medicine, Louisville, Kentucky Read the rest of this article »
Posted in 02-2009 (February 2009), Dermatitis, Original Research | No Comments »
Increasing Patient Adherence in Antifungal Infection Treatment Once-Daily Dosing of Sertaconazole
February 2009
Jeffrey M. Weinberg, MD
Department of Dermatology, St. Luke’s–Roosevelt Hospital Center and Beth Israel Medical Center, New York, New York
Disclosure: Dr. Weinberg is a speaker for and receives clinical research grants from OrthoNeutrogena. Editorial services provided by: Ann Braden Johnson, PhD, medical writer, and Medisys Health Communications, LLC. Supported by an educational grant from OrthoNeutrogena. Read the rest of this article »
Posted in 02-2009 (February 2009), Clinical Study Review, General | No Comments »
ALA–PDT and MAL–PDT: What Makes Them Different
February 2009
Therapeutic and Aesthetic Uses of Photodynamic Therapy
Part five of a five-part series
Michael H. Gold, MD
Medical Director, Gold Skin Care Center and The Laser & Rejuvenation Center, Nashville, Tennessee Read the rest of this article »
Posted in 02-2009 (February 2009), Photdynamic Therapy, Special Series | No Comments »
Teens and Tanning Knowledge and Attitudes
February 2009
Robin Ashinoff, MD, Director, Dermatologic, Mohs and Laser Surgery, Hackensack and University Medical Center, Hackensack, New Jersey; Vicki J. Levine, MD, Chief, Dermatologic and Mohs Surgery, New York University Medical Center, New York, New York; Alexa B. Steuer, Cresskill High School, Cresskill, New Jersey, Carly Sedwick, Quinnipiac College, Hamden, Connecticut Read the rest of this article »
Posted in 02-2009 (February 2009), Original Research, Tanning | No Comments »
February 2009
by Saira B. Momin, DO
James Q. Del Rosso, DO, FAOCD
Abstract
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare and serious cutaneous adverse reactions. There is controversy over the use of intravenous immunoglobulin (IVIG) in the treatment of SJS or TEN. The lack of randomized controlled trials to assess the benefits and risks of IVIG is due to its low prevalence and the high mortality rate associated with these cutaneous adverse reactions, especially in TEN. This article reviews published literature on case series that either supports or refutes the use of IVIG in the treatment of SJS or TEN. Read the rest of this article »
Posted in 02-2009 (February 2009), Questions-Challenges-Controversies | No Comments »
